Código QR (código de barras bidimensional)

Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis

BackgroundAnti-CD20 therapy with rituximab serves as the cornerstone of both induction and maintenance treatment for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, is designed for more potent and sustained B-ce...

Fuld beskrivelse

Na minha lista:
Principais autores: Chen Ye, Zhi-ying Li, Xiang-yu Han, Ming-hui Zhao, Min Chen
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2026-05-01
Serier:Frontiers in Immunology
Fag:
antineutrophil cytoplasmic antibody
B-cell
immunotherapy
obinutuzumab
vasculitis
Online adgang:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1787558/full
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker